Literature DB >> 20530055

Antiphospholipid antibodies and antiphospholipid syndrome: role in portal vein thrombosis in patients with and without liver cirrhosis.

Lucio Amitrano1, Paul R J Ames, Maria Anna Guardascione, Luis R Lopez, Antonella Menchise, Vincenzo Brancaccio, Luigi Iannaccone, Antonio Balzano.   

Abstract

UNLABELLED: The antiphospholipid syndrome (APS) has been associated with portal vein thrombosis (PVT). This study explored the contribution of antiphospholipid antibodies (aPL) to PVT in cirrhotic and noncirrhotic patients. PATIENTS AND METHODS: A total of 50 patients with liver cirrhosis and PVT, 50 patients with liver cirrhosis without PVT, 50 consecutive PVT without liver cirrhosis, and 50 controls. aPL tests: lupus anticoagulants (LAs), immunoglobulin G (IgG) anti-cardiolipin antibodies (aCL), IgG anti-beta-2-glycoprotein-I (β(2)GPI), and IgG β( 2)GPI-complexed with oxidized low-density lipoprotein antibodies (ox-LDL).
RESULTS: Lupus anticoagulants were negative in all patients. A titre of IgG aCL >40 IgG phospholipid units (GPL) was present in 2% of patients with liver cirrhosis and in none of the other groups. In all, 4% of patients with PVT without cirrhosis were positive for IgG β(2)GPI in the absence of any other positive aPL and labelled as primary APS.
CONCLUSIONS: aPL play no role in PVT associated with liver cirrhosis but can be tested in idiopathic PVT.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20530055     DOI: 10.1177/1076029610369797

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  2 in total

Review 1.  Associations of antiphospholipid antibodies with splanchnic vein thrombosis: a systematic review with meta-analysis.

Authors:  Xingshun Qi; Valerio De Stefano; Chunping Su; Ming Bai; Xiaozhong Guo; Daiming Fan
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

2.  Portal vein thrombosis in cirrhotic patients - it is always the small pieces that make the big picture.

Authors:  Irina Gîrleanu; Anca Trifan; Carol Stanciu; Cătălin Sfarti
Journal:  World J Gastroenterol       Date:  2018-10-21       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.